Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -32.06% is 44% above its 5-year average of -57.54%, near the high end of its 5-year range (-191.99%–-29.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 51.41% above its 12-month average of -65.98%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -32.06%.
RETURN ON INVESTED CAPITAL (ROIC)
-32.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-65.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-59.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-57.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-89.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-125.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+51.41%
CURRENT VS 3Y AVG
+46.55%
CURRENT VS 5Y AVG
+44.28%
CURRENT VS 10Y AVG
+64.16%
CURRENT VS 15Y AVG
+74.45%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
+6.90%
vs the sector median at left
Omeros Corporation
Market Cap
$1.34B
Return on Invested Capital (ROIC)
-32.06%
TTM Avg
-65.98%
3Y Avg
-59.98%
5Y Avg
-57.54%
Market Cap
$1.34B
Return on Invested Capital (ROIC)
-38.09%
TTM Avg
-38.09%
3Y Avg
-38.09%
5Y Avg
-38.09%
Market Cap
$1.32B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-45.26%
3Y Avg
-38.46%
5Y Avg
-34.74%
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-99.35%
TTM Avg
-175.72%
3Y Avg
-121.81%
5Y Avg
-100.94%
Market Cap
$1.41B
Return on Invested Capital (ROIC)
-24.52%
TTM Avg
-24.52%
3Y Avg
-24.52%
5Y Avg
-24.52%
Market Cap
$1.42B
Return on Invested Capital (ROIC)
5.22%
TTM Avg
4.86%
3Y Avg
3.97%
5Y Avg
3.44%
Market Cap
$1.42B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
-5.71%
3Y Avg
-17.68%
5Y Avg
-14.30%
Market Cap
$1.27B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-28.63%
TTM Avg
-6.26%
3Y Avg
-69.26%
5Y Avg
-69.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omeros Corporation (OMER) | $1.34B | -32.06% | -65.98% | -59.98% | -57.54% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.34B | -38.09% | -38.09% | -38.09% | -38.09% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -40.47% | -45.26% | -38.46% | -34.74% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -99.35% | -175.72% | -121.81% | -100.94% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | -24.52% | -24.52% | -24.52% | -24.52% |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 5.22% | 4.86% | 3.97% | 3.44% |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 47.55% | -5.71% | -17.68% | -14.30% |
| Kardigan, Inc. (KARD)vs › | $1.27B | -57.11% | -57.11% | -57.11% | -57.11% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | -28.63% | -6.26% | -69.26% | -69.26% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -53.48% | -44.88% | -46.83% | -39.47% |
ROIC
-32.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -32.06% |
| 2026-03-31 | -40.60% |
| 2025-12-31 | -46.40% |
| 2025-09-30 | -106.06% |
| 2025-06-30 | -104.78% |
| 2025-03-31 | -82.62% |
| 2024-12-31 | -77.44% |
| 2024-09-30 | -67.27% |
| 2024-06-30 | -58.84% |
| 2024-03-31 | -42.22% |
| 2023-12-31 | -49.33% |
| 2023-09-30 | -37.41% |
| 2023-06-30 | -34.65% |
| 2023-03-31 | -31.64% |
| 2022-12-31 | -29.76% |
| 2022-09-30 | -53.58% |
| 2022-06-30 | -69.37% |
| 2022-03-31 | -66.19% |
| 2021-12-31 | -62.99% |
| 2021-09-30 | -191.99% |
| 2021-06-30 | -153.69% |
| 2021-03-31 | -112.04% |
| 2020-12-31 | -76.64% |
| 2020-09-30 | -56.03% |
| 2020-06-30 | -263.97% |
| 2020-03-31 | -106.18% |
| 2019-12-31 | -74.56% |
| 2019-09-30 | -130.65% |
| 2019-06-30 | -168.05% |
| 2019-03-31 | -182.89% |
| 2018-12-31 | -191.57% |
| 2018-09-30 | -211.41% |
| 2018-06-30 | -94.66% |
| 2018-03-31 | -91.39% |
| 2017-12-31 | -48.76% |
| 2017-09-30 | -41.29% |
| 2017-06-30 | -136.40% |
| 2017-03-31 | -114.77% |
| 2016-12-31 | -105.99% |
| 2016-09-30 | -106.26% |
| 2016-06-30 | -223.98% |
| 2016-03-31 | -392.87% |
| 2015-12-31 | -217.09% |
| 2015-09-30 | -254.77% |
| 2015-06-30 | -148.44% |
| 2015-03-31 | -113.14% |
| 2014-09-30 | -429.44% |
| 2014-06-30 | -197.94% |
| 2014-03-31 | -122.57% |
| 2013-12-31 | -492.26% |
| 2013-09-30 | -1068.16% |
| 2013-06-30 | -298.77% |
| 2013-03-31 | -479.12% |
| 2012-12-31 | -213.74% |
| 2012-09-30 | -226.28% |
| 2012-03-31 | -345.74% |
| 2011-12-31 | -197.31% |
| 2011-09-30 | -106.86% |
| 2011-06-30 | -90.50% |
| 2011-03-31 | -86.26% |
| 2010-12-31 | -99.61% |
| 2010-09-30 | -84.34% |
| 2010-06-30 | -59.84% |
| 2010-03-31 | -45.28% |
| 2009-12-31 | -37.13% |
| 2009-06-30 | -548.15% |
